Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Cytal® Wound Matrix; Cytal® Burn Matrix

K-Number: K241724 · 2024-07-11

ApplicantAcell, Inc.
Decision Date2024-07-11
Product CodeKGN
DecisionSubstantially Equivalent

Device Summary

Cytal® Wound Matrix; Cytal® Burn Matrix is a medical device manufactured by Acell, Inc.. It received FDA 510(k) clearance on 2024-07-11 under approval number K241724. The device is classified under product code KGN. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Cytal® Wound Matrix; Cytal® Burn Matrix?

Cytal® Wound Matrix; Cytal® Burn Matrix is a medical device that received FDA 510(k) clearance on 2024-07-11. It is manufactured by Acell, Inc.. The 510(k) number is K241724.

When was Cytal® Wound Matrix; Cytal® Burn Matrix approved by the FDA?

Cytal® Wound Matrix; Cytal® Burn Matrix received FDA 510(k) clearance on 2024-07-11, under approval number K241724.

What company makes Cytal® Wound Matrix; Cytal® Burn Matrix?

Cytal® Wound Matrix; Cytal® Burn Matrix is manufactured by Acell, Inc..

What is the FDA product code for Cytal® Wound Matrix; Cytal® Burn Matrix?

The FDA product code for Cytal® Wound Matrix; Cytal® Burn Matrix is KGN.

Related Clinical Trials

NCT07613775 Volume-Stable Collagen Matrix Versus Subepithelial Connective Tissue Graft for Multiple Gingival Recessions NOT_YET_RECRUITING NCT07316192 Pelashield™ PainGuard™ vs Restrata® in HS Surgery RECRUITING NCT06073808 The Role of Amnion Membrane Allografts in Nipple Preservation NOT_YET_RECRUITING NCT06919809 Effectiveness and Safety of X A-DERM™ Microsurfaced Acellular Dermal Matrix for Wound Healing After MOHS Surgery COMPLETED NCT07546279 The Use of Two Bone Substitutes in Adjunct to EMD for the Treatment of One- and Two-wall Intrabony Defects. RECRUITING NCT06857708 The Management of Necrotizing Soft Tissue Infection Wounds With Cytal® Wound Matrix and MicroMatrix® RECRUITING

Other Devices by Acell, Inc.

K162554Gentrix Surgical Matrix K153754MicroMatrix K172399MicroMatrix K170763Gentrix Surgical Matrix Thick; Gentrix Surgical Matrix Extend K180776Cytal Wound Particulate K191734MatriStem UBM Pericardial Patch

View all 11 devices →

Related Devices (Code: KGN)

K160136Flowable Wound MatrixCook Biotech Incorporated K152600Collagen Dental Wound DressingsCollagen Matrix, Inc. K153754MicroMatrixAcell, Inc. K153690PriMatrix Dermal Repair ScaffoldTei Biosciences, Inc. K172010gel-e BandageGel-E, Inc. (Formerly Remedium Technologies, Inc.) K171842Geistlich Wound MatrixGeistlich Pharma AG

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑